BOSTON (Oct. 24, 2024) – Anaphylaxis can come on suddenly and without warning, and because its symptoms can be fatal, it is scary for those who encounter it. Two new studies being presented at this ...

Two new practice parameters from the Joint Task Force for Practice Parameters (JTFPP) offer evidence-based recommendations for the diagnosis and management of anaphylaxis and atopic dermatitis (AD) in ...

Misinformation and outdated protocols contribute to the suboptimal management of anaphylaxis by patients and healthcare professionals, based on data from two new studies presented at the American ...

Please provide your email address to receive an email when new articles are posted on . 23.7% of respondents said they would first use antihistamines for anaphylaxis. The top barrier to epinephrine ...

An international panel of experts has developed standardized definitions and treatment protocols for anaphylaxis, aiming to eliminate long-standing inconsistencies in emergency care. The Global ...

The event will provide an overview of Nasus Pharma and NS002, the Company’s epinephrine intranasal powder candidate in development for the treatment of anaphylaxis. The current standard of care for ...

Approximately 2% of adults and 4% to 8% of children have food allergies in the U.S., with food-induced anaphylaxis resulting in roughly 30,000 emergency department visits, 2,000 hospitalizations, and ...

ARS Pharma had high hopes that the FDA on Tuesday would approve its flagship product, a needle-free treatment for adults and children with severe allergic reactions. But instead, the drugmaker was set ...

Good news for those who suffer from severe allergic reactions: a nasal spray containing epinephrine rather than a needle can now treat those frightening moments. The treatment, called Neffy, was ...

Please provide your email address to receive an email when new articles are posted on . Omalizumab may effectively treat idiopathic anaphylaxis in patients without indication of mast cell clonality ...

A groundbreaking consensus report on anaphylaxis – the severe reaction some people experience from bee stings, peanut butter exposures, medications, and the like – has been released by the Global ...